Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies

Yasushi Isobe From the Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, JapanCorrespondence[email protected]

Naoko Kanemitsu From the Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

Yuriko Yahata From the Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

Azuchi Masuda From the Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

Yutaka Tsukune From the Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

Koichi Sugimoto From the Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-ku, Tokyo, Japan

References

Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730–941
PubMed Web of Science ®Google Scholar
Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, et al. Antimicrobial therapy of unexplained fever in neutropenic patients. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschft Supportivmassnahmen in der Onkologie (ASO). Ann Hematol 2003; 82(Suppl 2)S105–17
Google Scholar
Masaoka T. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: Executive summary. Clin Infect Dis 2004; 39(Suppl 1)S49–52
Web of Science ®Google Scholar
Fujimura S, Nakano Y, Sato T, Shirahata K, Watanabe A. Relationship between the usage of carbapenem antibiotics and the incidence of imipenem-resistant Pseudomonas aeruginosa. J Infect Chemothr 2007; 13: 147–50
PubMed Web of Science ®Google Scholar
Perry CM, Ibbotson T. Biapenem. Drugs 2002; 62: 2221–34
PubMed Web of Science ®Google Scholar
Falcone M, Micozzi A, Pompeo ME, Baiocchi P, Fabi F, Penni A, Martino P. Methicillin-resistant staphylococcal bacteremia in patients with hematologic malignancies: clinical and microbiological retrospective analysis of S. hemolyticus, S. epidermidis and S. aureus. J Chemother 2004; 16: 540–8
PubMed Web of Science ®Google Scholar
Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis 1998; 26: 1182–7
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical and microbiological effects of biapenem in febrile neutropenic patients with hematologic malignancies

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date